Paul Herrling

Director/Board Member at

University of Basel

80 year

84 connections

Health Technology

Commercial Services

Consumer Services

Profile

Paul Linus Herrling is currently a Trustee at The Scripps Research Institute, a Trustee at the University of Basel, a Vice President at the Swiss Federal Institute of Technology, and a Trustee at the Foundation for the National Institutes of Health, Inc. In the past, Dr. Herrling served as the Chairman at Novartis Institute for Tropical Diseases Pte Ltd., Director at Chiron Corp., Director at Novartis Institute for Functional Genomics, Inc., Director at Novartis International Pharmaceutical Ltd., and Head-Corporate Research at Novartis International AG.
He was also the Head-Corporate Research at Novartis AG, an Independent Member-Supervisory Board at Evotec SE, Head-Corporate Research at Sandoz AG, Head-Novartis Institutes at Novartis Institutes for Biomedical Research, Inc., and Head-Global Research at Novartis Pharma AG.
Additionally, he served as a Vice President at ETH-Rat from 2008 to 2018.
Dr. Herrling obtained a doctorate degree from the University of Zurich in 1975 and a graduate degree from the same university in 1971.

Paul Herrling active positions

Companies	Position	Start
University of Basel University of Basel Other Consumer ServicesConsumer Services Functions as a College/University	Director/Board Member	03/09/2010
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Director/Board Member	03/09/2010
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	03/09/2010
Foundation for the National Institutes of Health, Inc. Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare services	Director/Board Member	-

All active positions of Paul Herrling

Former positions of Paul Herrling

Companies	Position	End
ETH-Rat ETH-Rat ETH-Rat, also known as the ETH Board, is the strategic leadership and supervisory body of the ETH Domain, appointed by the Swiss Federal Council. The ETH Domain includes two federal institutes of technology (ETH Zurich and EPFL), four federal research institutions (PSI, WSL, Empa, and Eawag), and independent complaint bodies. The private company is based in Zurich, Switzerland. ETH-Rat is responsible for governance functions such as strategic leadership, financial and investment planning, real estate and infrastructure management, professorship planning and appointments, personnel matters, legislation, internal audit, risk management, and representation of interests within the ETH Domain. It oversees a real estate portfolio valued at approximately 4.3 billion CHF, ensuring infrastructure supports education, research, and technology transfer missions. ETH-Rat employs systematic controlling and delegates operational implementation to individual institutions, integrating real estate strategy with financial and investment planning on a rolling 12-year horizon. The organization has defined five priority areas for 2025–2028: human and health; energy, climate, and ecological sustainability; responsible digital transformation; advanced materials and key technologies; and engagement and dialogue with society. ETH-Rat manages delegated public-interest tasks, including oversight of specialized centers and services such as the Swiss National Atlas, Center for Security Studies, Swiss National Supercomputing Centre, Swiss Seismological Service, and National Air Pollution Monitoring Network. The ETH Domain promotes open science through its Open Research Data (ORD) program, investing in infrastructure, training, legal frameworks, and career development to enhance accessibility and sharing of scientific outputs.	Corporate Officer/Principal	01/01/2018
EVOTEC SE	Director/Board Member	14/06/2017
Novartis International Pharmaceutical Ltd. Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Director/Board Member	01/11/2016
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Corporate Officer/Principal	01/12/2011
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions	Chief Tech/Sci/R&D Officer	01/01/2010

See the detail of Paul Herrling's experience

Training of Paul Herrling

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul Herrling's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Chiron Corp. Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening	Health Technology
Novartis International AG Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Evotec SE Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services	Commercial Services
The Scripps Research Institute The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sandoz AG Sandoz AG Pharmaceuticals: GenericHealth Technology Develops generic medicines and biosimilars	Health Technology
University of Basel University of Basel Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Commercial Services
Foundation for the National Institutes of Health, Inc. Foundation for the National Institutes of Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare services	Commercial Services
Novartis Institute for Functional Genomics, Inc. Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine	Commercial Services
Novartis Pharma AG Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company	Health Technology
Novartis International Pharmaceutical Ltd. Novartis International Pharmaceutical Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
Novartis Institute for Tropical Diseases Pte Ltd. Novartis Institute for Tropical Diseases Pte Ltd. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapies for tropical infectious diseases	Health Technology
ETH-Rat ETH-Rat ETH-Rat, also known as the ETH Board, is the strategic leadership and supervisory body of the ETH Domain, appointed by the Swiss Federal Council. The ETH Domain includes two federal institutes of technology (ETH Zurich and EPFL), four federal research institutions (PSI, WSL, Empa, and Eawag), and independent complaint bodies. The private company is based in Zurich, Switzerland. ETH-Rat is responsible for governance functions such as strategic leadership, financial and investment planning, real estate and infrastructure management, professorship planning and appointments, personnel matters, legislation, internal audit, risk management, and representation of interests within the ETH Domain. It oversees a real estate portfolio valued at approximately 4.3 billion CHF, ensuring infrastructure supports education, research, and technology transfer missions. ETH-Rat employs systematic controlling and delegates operational implementation to individual institutions, integrating real estate strategy with financial and investment planning on a rolling 12-year horizon. The organization has defined five priority areas for 2025–2028: human and health; energy, climate, and ecological sustainability; responsible digital transformation; advanced materials and key technologies; and engagement and dialogue with society. ETH-Rat manages delegated public-interest tasks, including oversight of specialized centers and services such as the Swiss National Atlas, Center for Security Studies, Swiss National Supercomputing Centre, Swiss Seismological Service, and National Air Pollution Monitoring Network. The ETH Domain promotes open science through its Open Research Data (ORD) program, investing in infrastructure, training, legal frameworks, and career development to enhance accessibility and sharing of scientific outputs.